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ABSTRACT 
Objective: The Learning Health System (LHS) requires integration of research into routine 
practice. ‘eSource’ or embedding clinical trial functionalities into routine electronic health 
record (EHR) systems has long been put forward as a solution to the rising costs of research. 
We aimed to create and validate an eSource solution that would be readily extensible as part 
of a LHS.  
 
Materials and Methods: The EU FP7 TRANSFoRm project’s approach is based on dual 
modeling, using the Clinical Research Information Model (CRIM) and the Clinical Data 
Integration Model of meaning (CDIM) to bridge the gap between clinical and research data 
structures, using the CDISC Operational Data Model (ODM) standard. Validation against 
GCP requirements was conducted in a clinical site, and a cluster randomised evaluation by 
site nested into a live clinical trial. 
 
Results: Using the form definition element of ODM, we linked precisely modelled data 
queries to data elements, constrained against CDIM concepts, to enable automated patient 
identification for specific protocols and pre-population of electronic case report forms (e-
CRF). Both control and eSource sites recruited better than expected with no significant 
difference. Completeness of clinical forms was significantly improved by eSource, but Patient 
Related Outcome Measures (PROMs) were less well completed on smartphones than paper in 
this population.  
 
Discussion: The TRANSFoRm approach provides an ontologically-based approach to 
eSource in a low-resource, heterogeneous, highly distributed environment, that allows precise 
prospective mapping of data elements in the EHR.  
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Conclusion: Further studies using this approach to CDISC should optimise the delivery of 
PROMS, whilst building a sustainable infrastructure for eSource with research networks, 
trials units and EHR vendors. 
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1.1 INTRODUCTION 
The Randomised Clinical Trial remains the standard for approval of new treatments in 
healthcare. [1] Data standards for research data collection have been formulated by the 
clinical trials community via The Collaborative Data Standards Interchange Consortium 
(CDISC) over several decades, with an established pathway for data management from source 
to submission for regulated clinical trials. Using CDISC standards has led to a steady move 
away from paper case report forms (CRFs) towards electronic data capture (EDC) systems. 
Given the rapid expansion of the use of electronic health record (EHR) systems in clinical 
settings, it has been proposed that EHRs could be the primary point of data entry for a clinical 
trial. However, direct collection of data into digital form, referred to as eSource, can only be 
achieved if the EHR is able to support research quality data collection.[2] Good Clinical 
Practice (GCP) principles need to be adopted to ensure that the requisite standards are in 
place for eSource, while changes are made to the data collection process and governing 
regulations to fit in with this electronic context.[3] Moving towards eSource, the Integrating 
the Healthcare Enterprise (IHE) collaboration (www.ihe.org)[4]  has developed a set of 
profiles including the Retrieve Form for Data Capture (RFD) and Retrieve Process for 
Execution (RPE), specifying forms and workflow respectively. Several proof-of-concept 
studies using IHE profiles have been completed.[5]These include STARBRITE, a single site 
proof of concept implementation within a clinical trial in heart failure patients, that took place 
nine years ago, without further progress in the field.[6] Complementary to these have been the 
efforts of the i2b2 community (www.i2b2.org) that has been utilising RedCap software 
(www.project-redcap.org) to design study forms and collect data directly into i2b2 data 
warehouses, rather than the EHR.[7] 
 
Within the academic and pharmaceutical trials world there has been a move to ‘real world’ 
clinical trials (also known as ‘pragmatic’ clinical trials) as a means of gathering more  
representative data, at lower cost, on the likely effectiveness of treatments, to satisfy 
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increased regulatory requirements in this area.[8] Real World clinical trials have simple 
inclusion and exclusion criteria, are conducted in clinical settings where the treatment will be 
used, using ‘current standard care’ rather than placebo as a comparator, and have outcomes 
collected as a combination of routine clinical contacts and Patient Reported Outcome 
Measures (PROMs). [9] These outcomes are often used as the basis for an economic analysis. 
The results of such studies are likely to be closer to the ‘in practice’ clinical effectiveness and 
impact of a treatment than the efficacy determined by a typical phase III study against 
placebo in highly selected subjects. Real world trials are subject to the same effects of co-
morbidity, heterogeneity and lack of blinding that accompanies real world use of a treatment. 
As real world trials take place in routine clinical settings, a compelling case can be made for 
eSource, using the existing EHR to support the study.[10] It has been proposed that 
embedding research into routine EHR systems, could automate a substantial part of the trial’s 
screening process.[11] Eligibility criteria can be partially tested against EHR patient data and 
electronic case report forms (eCRFs) can be pre-filled with data present in the EHR, in order 
to minimise unnecessary manual entry. In addition, clinical data collected within a trial 
should be made available in the EHR, in order to enhance routine clinical care and safety 
monitoring.[12][13]  
 
Real world trials have not yet progressed to using eSource by default, still requiring a large 
investment in data collection and validation.[14] Closing this step would go a long way to 
providing an end-to-end ‘research and learning’ continuum for a Learning Health System 
(LHS), where research and knowledge translation are routinely transacted via ICT systems. 
Use of robust data standards, such as the CDISC suite, when interacting with EHRs, are 
essential to the operation of the LHS in order to overcome the ‘silo of excellence’ culture 
prominent in healthcare research, and lower the barrier to entry for traditional clinical 
environments.[15] In this paper, we describe an approach to embedding clinical trial 
functionality within the EHR systems, enabling the pre-population of eCRFs directly from the 
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EHRs, and the potential of recording of CRF data, collected during research, within the EHR 
system. This paper describes the methods we adopted to create semantically enriched and 
model-based extensions to existing standards, how we implemented these in live EHR 
systems, and how we validated and then evaluated the technical functionality of the approach 
in a live clinical trial as part of a large European research programme. 
 
1.2 The TRANSFoRm infrastructure 
The European FP7 TRANSFoRm project aimed at developing an infrastructure for a Learning 
Health System in European Primary Care (www.transformproject.eu),[16] a major 
workstream of which was directed at developing eSource connectivity for randomised 
controlled trials (RCT). Primary Care represents the ultimate low-resource, heterogeneous, 
highly distributed environment, especially when the multi-language, multi-health system 
dimensions of Europe are added.  
 
Under the IHE approach, only single EHR systems have been used to deploy standard forms, 
pre-populated with limited EHR data. In each case, the study data collection requires the use, 
or at least conformance, to a minimum set of data elements defined in CDASH (Clinical Data 
Acquisition Standards Harmonization),[17] and the EHR system needs to be capable of 
collecting and managing the CRFs, possibly with custom extensions. This approach requires a 
large academic centre for conducting trials, with support for a complex IT infrastructure, and 
the close participation of EHR vendors. TRANSFoRm, on the other hand, had to consider the 
requirements of multi-site, multi-system data collection with a low resource overhead, such 
that the LHS can encompass a range of healthcare system at various levels of IT maturity, not 
just large academic centres. Therefore, what is required is a readily extensible framework, 
enabling researchers to define clinical data elements to research standards like CDISC and to 
semantically align them to native EHR data. TRANSFoRm has taken an approach of using 
existing CDISC standards, but referencing a core data model, expressed as an ontology, to 
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provide a flexible and more streamlined approach. The requirements established for 
TRANSFoRm are shown in Table 1.  
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Clinical study requirements: 
1. Prevalent and incident case identification from live EHR systems in primary care 
2. Real time alerting when a case is identified via EHR 
3. Pre-population of CRFs displayed within the EHR user interface 
4. Data capture in EHR fulfilling the eSource requirements of GCP (noting that if 
blinded, treatment allocation must remain concealed). These include data provenance 
and validation of data capture and transfer accuracy. 
5. Patient Related Outcome Measure data captured electronically and stored in the EHR 
for Safety monitoring 
6. Data provenance – towards compliance with 21 CFR Part 11 and European regulation 
7. Full evaluation in 5 EU member states and in the context of a real world RCT 
Technical requirements: 
8. To use ontologies to maintain models of meaning for the LHS, terms being bound to 
clinical concepts 
9. To use CDISC foundational standards including the Operational Data Model and 
(ODM), and the Study Data Model (SDM) 
10. To enable connection to multiple country, multiple language, multiple vendor 
systems with minimal vendor input 
Vendor requirements: 
11. Standard Terminology used in EHR  
12. Sample EHR data set available for testing 
13. Represent local database metadata as a model (DSM) and map to TRANSFoRm 
Clinical Data Integration Model (ontology) 
14. Availability of an Application Programming Interface (API) and a demo installation 
for testing (or the vendor builds the DNC functionality into their system) 
Table 1: Requirements for embedding RCTs in an EHR as part of a LHS. 
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2. MATERIAL AND METHODS 
2.1 General approach 
TRANSFoRm took a unified approach to workflow and data integration for the entire project, 
described previously.[16] The requirements and workflow of the research process are first 
expressed using the Clinical Research Information Model (CRIM),[18] a domain-specific 
implementation of CDISC’s Biomedical Research Integrated Domain Group  (BRIDG).[19] It 
is, for example, the role of CRIM to direct when in the workflow a query should be used for 
retrieving patient study data from aggregated EHR data repositories. When required, in order 
to extract data from clinical sources, the unified interoperability framework separates the 
stable domain information from the heterogeneous data sources to achieve structural and 
semantic interoperability between different actors in the LHS (clinical investigators, EHRs, 
researchers, CRFs).[20–22] It works by binding structural and terminological models (of both 
the domain and the sources) in order to derive the full semantic meaning of clinical 
data.[21,23]  The clinical primary care domain is specified, using the Clinical Data 
Integration Model (CDIM),[24] an ontology that enables users to work with data and express 
queries using neutral clinical concepts, without needing any knowledge about the specific 
schema of the target data source. CDIM offers a unified view of the primary care domain and 
CDIM has been developed as a realist ontology, all of whose classes have instances in the real 
world, and works in conjunction with medical terminologies that provide concrete 
instantiations. CRIM and CDIM models together specify the data flow through 
TRANSFoRm's infrastructure. 
 
2.2 ODM and eSource 
The CDISC Operational Data Model (ODM) is a vendor neutral, platform-independent XML 
format for interchange and archive of clinical study data, designed to facilitate regulatory-
compliant acquisition, archive and interchange of data and metadata for clinical research 
studies (http://www.cdisc.org/odm). ODM's <FormDef> element captures eCRF 
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composition and structure, with <ItemGroupDef> elements used to group related items 
(e.g. a systolic blood pressure measurement value, the unit of measure and the time at which 
it was measured), with <ItemDef> elements containing specific item metadata. As shown in 
Figure 1, we used <ItemGroupDef> to reference research data queries expressed using 
CRIM, and <ItemDef> to define clinical data elements referencing the CDIM ontology. As 
both these elements are contained within <FormDef>, the necessary model constraints are 
applied. Our key requirements were pre-population of forms from existing EHR data and 
controlled data elements in the EHR. In order to embed an EHR data extraction request into 
ODM, <ItemGroupDef> was extended by adding a <QueryId> child element, 
containing a unique identifier linking the item group with the corresponding query. CDIM is 
used to annotate <ItemDef> through its <Alias> element, which allows binding to an 
external model using the context attribute (e.g., CDIM_2.2) and the value attribute (e.g., 
CDIM_000070). As an ontology-based mediation, the pre-population query does not contain 
source specific structural information and is used for every source. Once the embedded Data 
Extraction Queries have been translated for the specific source by the TRANSFoRm 
interoperability framework and executed, the results are annotated with CDIM concepts and 
placed in the proper <ItemDef>, as identified by the <Alias> element. In this way, 
TRANSFoRm’s dual-level modelling enables data interoperability between EHR patient data 
and the ODM. PROMs are collected using a separate smartphone and web application using 
the TRANSFoRm ODM extension to specify the mobile and web data collection.[25] 
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Figure 1: CDISC and TRANSFoRm eSource interactions 
 
2.3 Validation  
A clinical use case was developed to guide the development, validation and evaluation of 
TRANSFoRm. The gastro-oesophageal reflux disease (GORD) study aimed to assess the 
effectiveness of TRANSFoRm in patient recruitment and answer the following clinical 
question: “What gives most symptom relief and improvement in quality of life (QoL) in 
patients with GORD, on demand or continuous use of proton pump inhibitors?”.[26] 
Preparations took place between late 2013 and early 2015 in Poland, beginning with the 
integration of the vendor system (mMedica from Asseco Poland S.A.) and the TRANSFoRm 
platform through a single platform component, the data node connector (DNC), which 
brokers communication with the TRANSFoRm study system and other platform components. 
The intention of the validation study was to ascertain the accurate functioning of the 
TRANSFoRm tools and to carry out a Good Clinical Practice (GCP) certification. GCP is a 
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requirement for the use of data collection systems in regulated clinical research, in the US 
known as 21 CFR 11.[27] 
 
A simulated study with 10 process scenarios was designed.[28] The software was installed in 
practices and data collection scenarios carried out by Polish clinicians and TRANSFoRm staff 
acting as patients. The training plans were also designed and tested with pilot users. The 
installation and regular operation of TRANSFoRm components, including data collection 
tools, TRANSFoRm study system and the data node connector, were documented through a 
set of Installation Qualification, Operation Qualification and Performance Qualification tests, 
all performed on the pilot trial site. The development teams involved in software production 
were themselves assessed in terms of training, software quality assurance procedures and 
institutional policies.  
 
2.4 Evaluation 
It has been suggested that a robust way of evaluating methodological innovation in clinical 
trials is the ‘SWAT’, or ‘Studies within a Trial’ design, where a second randomisation 
allocates study subjects or sites to a alternative methods of delivering the main trial.  
Following this approach.[29] We aimed to conduct a mixed-methods evaluation of the 
TRANSFoRm eSource method as a nested cluster randomised trial  embedded fully within an  
RCT (700 subjects, individually randomised). The studies were conducted across five 
countries and five different EHR systems (EudraCT trial number 2014-001314-25), according 
to a published protoco.[26] Ethical approvals were obtained in the UK, Netherlands, Belgium, 
Poland and Greece. The Study Sponsor was the Karolinska Institute, Sweden. The aim of the 
evaluation study was to compare the TRANSFoRm tools to standard methods for 
opportunistic clinical trial recruitment in primary care, which are largely based on searches of 
patient records conducted within a given EHR system, without any ‘real time’ alerts.[30] The 
Clinical RCT results will be published separately. The primary outcome of the study was 
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recruitment rate, based on an effect size of the TRANSFoRm system increasing recruitment 
of subjects by 75% (RR 1.75, based on a baseline of 20% in the control arm. We aimed to 
measure the denominator of eligible subjects across centres via searches of the EHR at study 
end, as a very high proportion of primary care encounters are coded, enabling efficient 
measurement of patients meeting the eligibility criteria in each arm across centres.[31][32] 
The secondary outcomes were recruitment per week per site and data completeness.  
The practices in the TRANSFoRm arm had the TRANSFoRm software installed in the 
practice and were trained in using the software by TRANSFoRm staff. The eCRF system 
used in the control arm consisted of a basic web-based electronic case report form with built 
in randomization algorithm identical to that used in the TRANSFoRm eCRF tool, but with no 
EHR interaction, thus lacking the capabilities to support patient recruitment by flagging 
eligible patients, and prepopulating forms with EHR data. Patients completed the PROM on 
paper and the questionnaire was sent to the local study coordinator for data entry. (Table 2) 
Differences in recruitment rate between the TRANSFoRm arm and the control arm were 
calculated using Wilcoxon matched-pairs signed-ranks test and the pairing from the 
randomization of the practices to the TRANSFoRm vs the control arm was used. Differences 
in completion rate were analysed using two sample test of proportions. 
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 TRANSFoRm Control 
Recruitment 
(consecutive) 
Flagging patient in EHR Manual identification of eligible 
patients from the EHR 
Informed consent Signed paper Signed paper 
Randomisation Automatic in eCRF Automatic in eCRF 
Data Elements Standardised via CDISC ODM 
and CDIM 
No standardisation 
CROM collection eCRF integrated with EHR 
and prepopulated with EHR data 
Web based eCRF with no pre-
population 
PROM collection Web/Smart Phone application 
also based on an ODM xml 
document 
Printed questionnaires distributed 
by practices, prepaid envelopes 
provided. Data entered manually 
into database 
Monitoring Reporting workbench Manual 
Data saved Recoverable from EHR  Not saved to EHR 
Provenance Traced via system Not traced 
Table 2: Conditions for TRANSFoRm system and control sites (CROM= Clinical Related 
Outcome Measures, PROM = Patient Related Outcome Measures) 
 
 
3. RESULTS 
3.1 Implementation of the research platform components and workflows with vendors 
We worked with five EHR vendors, practices using the EHR system were then approached 
and asked to participate. Eight to ten practices per vendor were included in the study, and 
altogether 36 practices participated in the study: 8 in Greece (University of Crete TRANSHis 
variation), 10 in Poland (Asseco Mmedica), 8 in the Netherlands (Dutch TRANShis) and 10 
in UK (In Practice Systems Vision3). In the UK 10 practices using The Phoenix Partnership’s 
SystmOne could not take part as the integration with TRANSFoRm was not completed on 
time. The system required on-site configuration via third-party practice ICT support that was 
hard to engage. The Belgian vendor’s EHR system deployment was delayed for commercial 
reasons and there were no practices using the system to recruit. Vendor’s involvement 
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consisted of providing an XML data source model describing their patient data schema, as 
well as providing some form of API for communication with the DNC – the latter we found 
already present in all the EHRs we recruited.  The effort involved in this work, over and 
above that already being carried out by the EHR vendor, consisted of some administration of 
non disclosure agreements, answering queries around the use of the API and conformance 
testing of the DNC prior to its installation in sites. 
 
The TRANSFoRm Study System (TSS) is centrally hosted at a secure location and holds the 
study information and protocols, defined via ODM files. It also acts as the research repository 
for the collected eCRF data. The coordination of study activities at the local level is 
performed by the data node connector (DNC) components, which sit locally to the EHR 
instances. All research data capture operations (e.g., eligibility checking), eCRF pre-
population and eCRF completion, are orchestrated and performed by the DNC. Thus the data 
flow between the EHR and the DNC remains local to the EHR and only the data identified for 
research purposes is sent to the research repository in line with the project’s security and data 
protection framework.[33] The DNC can pull data from the TSS but the TSS cannot push data 
to nor pull data from the DNC as initiator of the communication. The latter is important as 
often the DNC will sit behind an organisational firewall in a clinical setting. The DNC is 
started with the host EHR system and obtains from the TSS information about the currently 
active study protocols and their eligibility criteria. The generic study definitions are then 
translated by the Semantic Mediator (SM) component into locally executable queries. When a 
patient arrives for a consultation, their record is sent to the DNC as an XML document, where 
it is checked for eligibility. The TRANSFoRm platform does not mandate a specific structure 
or model for that file, which usually corresponds to the EHR system’s native format.  
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Figure 2: TRANSFoRm study workflow for the GORD trial. 
 
TRANSFoRm workflow is shown in Figure 2. When a presenting patient is found to be 
potentially eligible for a study, the DNC notifies the clinician of the eligibility via a pop-up 
message requesting completion of eligibility checks and consent/randomisation. Thereafter 
when the recruited patient presents at the practice, the DNC retrieves the appropriate eCRF 
forms from the study system, transported as HTML forms parameterised for pre-loading and 
storage of field values, together with the corresponding CDISC ODM document container 
with the ClinicalData section parameterised to store the data values entered into HTML fields. 
The generation and parameterisation of the HTML and ODM documents is performed by the 
TRANSFoRm Study System based on a pre-established ODM to interface translation, OID, 
QueryID and CDIM alias. Using this information, the DNC can correctly pre-load form fields 
by applying the queries to the patient data extract and inserting the resulting values at the 
corresponding place in the form. The pre-loaded HTML form can then be presented to the 
clinician for validation and entry of data items that have not been pre-loaded. The form can 
either be embedded into the EHR or accessed through a web browser. 
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Once approved, the form is submitted to the DNC where data is inserted in the ODM file. The 
DNC then sends the ODM document containing the responses from the form to the TSS for 
research activities. It also sends the associated ODM files and HTLM forms to the EHR for 
auditing purposes and reviewing by clinicians at a later date, if required. The EHRs currently 
partnering with TRANSFoRm do not store the form field data as individually coded facts, but 
as a single artefact which can be viewed as a whole. While the mappings between the patient 
data extract and CDIM could be used to support granular transfers back to the EHR, the 
vendors preferred not to explore this aspect in the first version. Data elements that were pre-
populated and their availability in each system are shown in Table 3. Data flow and document 
examples are shown in supplementary material on-line. 
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Data element Ontology 
ID 
Asseco_nMedica 
(PL) 
InPS_Vision 
(UK) 
TransHIS (NL) 
TransHIS (GR) 
Patient clinical research ID 
symbol 
CDIM/3 Y Y Y 
Gender role OMRSE/7 Y Y Y 
Human birth instant CDIM/7 Y Y Y 
Health encounter instant CDIM/79 N Y Y 
Physician practice† OMRSE/17 [1] [1] Y 
Diagnostic conclusion OGMS/73 Y/ICD10 Y/ReadV2 Y/ICPC 
Diagnostic conclusion instant CDIM/12 Y Y Y 
Symptom OGMS/20 N Y N 
Mass measurement datum CDIM/68 Y Y Y 
Mass measurement instant CDIM/67 Y Y Y 
Mass measurement unit label CDIM/100 [kg] [kg] Y 
height measurement datum CDIM /71 Y Y Y 
height measurement instant CDIM /70 Y Y Y 
height measurement unit label CDIM /88 [cm] [cm] Y 
sys BP measurement datum CDIM /73 Y Y Y 
sys BP measurement instant CDIM /102 Y Y Y 
sys BP measurement unit label CDIM /84 [mmHg] [mmHg] Y 
dia BP measurement datum CDIM /74 Y Y Y 
dia BP measurement instant CDIM /101 Y Y Y 
dia BP measurement unit label CDIM /83 [mmHg] [mmHg] Y 
formulated pharmaceutical item CDIM /37 Y/ATC Y/MultiLex Y/ATC 
Rx instant CDIM /105 Y Y Y 
Laboratory test OGMS/56 N Y/ReadV2 Y/LOINC 
Laboratory measurement scalar 
value 
CDIM/32 N Y Y 
Laboratory confirmation instant CDIM/29 N Y Y 
Laboratory measurement unit 
label* 
CDIM/81 N N Y 
Table 3: Pre-populated data elements and coverage by system 
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Notes: 
[] indicates implicit values for a data element which are directly specified in the structural 
mapping model. 
* Failure to identify an explicit laboratory unit label had no consequences since 
TRANSFoRm-1 did not perform unit conversion. 
† Physician practice was always accessed as ‘current physician’ 
 
3.2 Validation study  
In order to achieve GCP certification, the TRANSFoRm system underwent a series of tests, 
including Installation Qualification, Operational Qualification and Performance Qualification. 
These tests established the functional correctness of the system, with respect to the 
requirements and specification, and also establishing the integrity of the data that is output 
from the system. The non-functional aspects examined included training materials, technical 
support, skill level of the development teams, and software quality assurance procedures. 
Post-installation support was provided by members of the TRANSFoRm and vendor teams 
covering the use of the updated vendor software and supporting TRANSFoRm software. 
Most issues arose from the sequencing of forms to be filled within the EHR system. In the 
cases where this was implemented by the vendor, it is necessary to check that forms will be 
submitted in the correct order. Extensive logging by the TRANSFoRm DNC meant that a full 
record of these issues could be maintained and there was less reliance on GP reporting to 
understand these issues. A full description of the validation related to usability is published 
elsewhere.[28] 
 
3.3 Evaluation study 
The number of recruited patients in the TRANSFoRm and control arm in all four localities 
and in total is presented in Table 4. The total number of recruited patients exceeded 600 and 
was very similar between the TRANSFoRm and the control arm. Greece and Poland stood for 
the vast majority (96%) of all recruitments.  
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 TRANSFoRm arm Control arm Total 
Greece 122 121 245 
Netherlands 10 6 16 
Poland 156 177 333 
UK 5 3 8 
Total 293 307 600 
Table 4: Recruitment of subjects by site and arm. 
 
Greece and Poland were used to compare recruitment rates between the TRANSFoRm arm 
and the control arm. Eight pairs of practices were available for analysis. The total number of 
patients recruited was very similar between the arms. The total number of eligible patients 
was higher in the TRANSFoRm arm, as there was one practice that had a very long 
recruitment time and consequently a high number of eligible patients according to the EHR. 
The study was powered to detect an increase in the recruitment rate from 20% to 35%. The 
average recruitment rate was 43% in the TRANSFoRm arm and 53% in the control arm with 
a large range in recruitment rate between practices. There was no significant difference in 
recruitment rate between the TRANSFoRm arm and the control arm nor was there a 
statistically significant difference in number of recruited patients per week between the two 
arms (mean TRANSFoRm=2.84 recruited patients per week vs mean control 2.39 recruited 
patients per week, p=0.67).  
 
All localities were included in the comparison of completion rate in the TRANSFoRm arm 
compared to the control arm. In the TRANSFoRm arm, 85% of those with a first Clinical 
Reported Outcome Measure (CROM) had a filled 2nd CROM, while in the control arm this 
was true for 71 % (p<.001). In the TRANSFoRm arm, 61% of patients with a first PROM had 
also filled out 2nd PROM, as compared to 100% in the control arm (p<.001). Hence, the 
TRANSFoRm tool supported CRF data collection significantly better while the manual 
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distribution of questionnaires was superior to the use of the mobile/web app for PROM data 
collection.  
 
4. DISCUSSION 
TRANSFoRm has shown that the process of integrating clinical trial process and data 
management into the EHR can be based on CDISC standards without demanding significant 
workload from the EHR vendors. A recent review of embedding RCTs for effectiveness in 
EHRs, that referenced some of our earlier work that informed TRANSFoRm,[13][10] 
concluded that ‘substantial re-engineering of the EHR is required to allow for trial 
workflow.[34] Our work shows how barriers to adoption can be lowered and increasing the 
uptake of the LHS, whilst retaining compatibility through use of standards. The key 
components of this approach are not specific to TRANSFoRm, but extensions to the CDISC 
approach as follows: 
1. An ontology or a data model appropriate to the domain to bind to data elements, 
better defining their model of use in the clinical domain (CDIM) 
2. Reference to ontology of EHR data mappings, mostly these will be references to 
tables in the EHR, but a detailed clinical data element definition and underlying 
model can be used if those definitions are in clinical use 
3. A study system for managing artifacts and models, definitions etc and transacting 
workflow (TSS) 
4. A local Data Node Connector for linking the TSS to EHR systems. 
None of these components are specific to a particular platform and can be replaced by 
alternative versions (e.g., locally developed) that conform to the TRANSFoRm models. 
 
The adoption of CDIM to represent a shared ‘model of meaning’ allows the separation of 
definition from implementation.[21] ODM is maintained as the key standard, with references 
binding item definitions to CDIM and embedding the research meaning as a precisely defined 
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query, structured and guided by CRIM. CDIM, in conjunction with relevant terminologies, 
allows expression of precise, complete and fine-grained clinical concepts as required by the 
LHS - answering the needs of users as well as catering to data sources with varying 
granularity. This simple method is anchored into a foundation model (CDIM) that allows for 
a high level of granularity and precision while supporting various logical operators as well as 
covering a wide range of terminologies, including the UMLS. The outlined approach is 
generalizable to other domains as different domain specific models can be created. We re-
used higher level concepts to ensure future compatibility by using BRIDG for CRIM and 
building CDIM from middle level ontologies.[35,36] A number of approaches have been 
taken to allow the creation of various data elements ‘defined sets’ with different level of 
granularity and detail (ISO11179 Ed3,[37,38] CDISC CDASH,[17] ISO13606,[39] CIMI [5]). 
While this flexibility is essential to define data elements purely for research purposes, when 
applied to clinical interoperability, this can quickly lead to a profusion of overlapping data 
elements with minuscule variations. This is especially problematic when put in context of 
organizing data flows between the research data structures and the EHRs. Mappings need to 
be created between EHRs and data elements. All these slight variations can confuse and 
complicate mapping creation and maintenance. Moreover, to work effectively, links between 
the EHRs and the data elements need to be established prospectively in order to avoid the 
need to create a new mapping each time a new data element is derived with a slightly 
modified definition. Our approach circumvents this problem by using ODM, defining data 
elements via CDIM, and mapping them into the EHR’s native terminology, passing the 
resulting terms to ODM. 
 
As described earlier, an alternative approach to linking to EHR systems has been taken by 
IHE and the CDISC Healthcare Link Initiative (HCL) whereby the process of integration is 
undertaken by EHR vendors.[4] The TRANSFoRm approach should not be seen as a 
competitor to IHE, but an attempt, in the context of an academically-led project to streamline 
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the process of using CDISC standards for small vendors such as those found in primary care 
and specialist clinical areas.  Table 5 compares the TRANSFoRm and HCL/IHE approaches. 
The two approaches are not mutually exclusive. Both the TRANSFoRm and IHE approaches 
can co-exist by using the <ItemDef> element as a pivot by using two aliases: one to 
CDASH and one to CDIM. Maintaining clinical meaning via an ontology should be seen as 
desirable in the context of the LHS, where a basic reasoning capability is important in 
maintaining coherence across a distributed research and translational system. [40,41] 
 
The recent completion of SHARE by CDISC, creating a single repository of both CDISC 
standards and artefacts from forms to data elements, offers potential to develop an integrated 
solution whereby CDIM and TRANSFoRm data elements and queries could be made 
available via SHARE. This would require careful consideration of CDISC subscriptions and 
the need to cover a variety of industry, academic and clinical users.  
 
 
  
Ethier et al.  21 
Requirement HCL TRANSFoRm 
Form specification ODM ODM 
Research CDE definition CDASH External model (e.g. 
CDASH) with mapping to 
CDIM Ontology[35,36] for 
pre-populated elements. 
Research CDE storage and 
distribution 
CDISC SHARE (ISO11179) Not implemented could be 
using CDISC SHARE 
Research CDE mapping to 
clinical DE 
Data Element Exchange 
(DEX) 
CDIM ontology referenced 
by ItemDef Alias 
Pre-population specification 
of query 
SDM (xpath) via DEX CDISC Study Data Model 
(xpath) via pre-specified 
queries referenced by ODM 
ItemGroupDef QueryID 
Pre-population extraction of 
EHR data 
Retrieve Process for 
Execution and HL7 Clinical 
Research Document 
Via Data Node Connector 
and EHR API 
Semantic mapping CDASH – restricted code set TRANSFoRm Terminology 
Service (LexEVS) augmented 
by manual term selection and 
binding 
Display of CRFs Retrieve Form for Data 
Capture Profile – proforma 
implemented by EHR system 
Via Data Node Connector 
and EHR API 
Data storage from CRFs Archive TSS (vie Data Node 
Connector) 
Audit and change control Archive Open Provenance Model, 
provenance trace recorded 
with operation of 
tools.[42,43] 
Security and authorisation Within EHR TSS (inherited from local 
authorisation) 
 
Table 5: Key differences between HCL and TRANSFoRm.  
(HCL - CDISC Healthcare Link; ODM – Operational Data Model; CDE – Common Data 
Element; CDASH – Clinical Data Acquisition Standards Harmonization; CDISC SHARE – 
Shared Health and Clinical Research Electronic Library; MDR – Metadata Repository; DEX 
– IHE Data Element Exchange; SDM – Study Design Model; RPE – IHE Retrieve Protocol 
for Execution; CRD – IHE Clinical Research Document; RFD – IHE Retrieve Form for Data 
Capture; TSS – TRANSFoRm Study System) 
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In the RCT we recruited more than 600 patients bringing us close to the goal of 700 recruited 
patients. However, the meta-RCT evaluation study became underpowered compared with our 
initial plans as no data was contributed to the analysis from the UK (2 sites, 20 practices) or 
The Netherlands and 8 rather than the 20 planned pairs of practices included in the analyses.  
 
The TRANSFoRm approach was successfully validated and shown to conform with the 
necessary GCP requirements to conduct the evaluation study. A very strong reactivity meant 
that all the Polish and Greek sites recruited more efficiently in both arms than we had 
expected. We had decided to compare recruitment rates with active sites in the TRANSFoRm 
and control arms rather than include the effect of start up delays in the eSource sites, as we 
viewed this as a one off set-up rather than an issue with future studies. The trials-within-trials 
approach to evaluation of methodological innovations in clinical trials is likely to face 
problems with power unless a basket of RCTs are used across each innovation, the clustering 
effects of RCT protocols being taken into account in subsequent analysis.  
 
A defining principle of a Learning Health System is that it is universal, encompassing both 
new state-of-the-art research environments and the traditional clinical settings with no 
advanced informatics infrastructure. Our goal therefore is to be able both to define meaning at 
the system level and also enable incorporation of legacy systems where there is not the 
resource to develop and maintain separate infrastructures for research within the clinical 
system. Development of an open and transparent approach to using ‘data transfer’ standards 
such as ODM and FHIR, along with ontologies and mappings between detailed clinical 
terminologies or models, coupled with robust provenance will form the basis for the 
consistent clinically-rich data standards necessary for the operation of the LHS at scale. It is 
only through such inclusive approaches, that we shall fulfil on the promise of the LHS and 
achieve its wider take-up. 
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